$4.1 million funding supports epilepsy treatment research using spider venom proteins

UQ researchers have received $4.1 million from the Medical Research Future Fund to advance their research into epilepsy treatments made from spider venom proteins.

FDA expands Enhertu approval to include HER2-ultralow breast cancer patients – Pharmaceutical Technology

The approval allows certain patients to receive Enhertu earlier in their treatment course. Credit: FatCamera via Getty Images. AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate (ADC)

January 29, 2025

Study reveals the unseen toll of silent burps on quality of life and mental health

The inability to burp-; called retrograde cricopharyngeus dysfunction (R-CPD)-;is caused by failure of the throat’s cricopharyngeal muscle to relax to allow the outward passage of

December 21, 2023

Fold Health Lands $6M for Optimization Platform for Primary Care

What You Should Know: – Fold Health,a San Francisco, CA-based platform supporting value-based primary care raises $6M in funding from Iron Pillar and global angel

July 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.